Objective To study the role of diuretic agents in treating sudden deafness (SD) and explore the possibility of endolymphatic hydrops as a potential cause of SD. Methods Twenty-eight SD cases were reviewed. In 23 cases, treatment was initiated with routine agents. Diuretic agents were later added in 8 of these cases that failed to respond to routine treatment agents. Diuretic agents were included in the ini• tial treatment in the rest 5 cases. In total, 13 cases received diuretics in addition to routine treatment agents and 15 cases received conventional treatment only. Results In the 8 cases who received diuretics after failed conventional treatments, 4 showed hearing improvement, whereas all 5 cases in which diuret• ics were included in the initial treatment demonstrated hearing improvement. Conclusion These results suggest a possible role of endolymphatic hydrops in the pathophysiologic course of SD. Diuretics should be considered when clear indications exist with no conflicts to other medical conditions.
Introduction
Sudden deafness(SD)is a symptomatic diagnosis, and its etiopathogenesis remains to be deter• mined. Proposed causes include viral infection, mi• crocirculation disorder and autoimmune disor• ders. Accordingly, routine treatments include vaso• dilation, reduction of blood viscosity and adminis• tration of neurotrophic suppliments. Some reports have proposed that endolymphic homeostasis may be a potential cause of SD. In the current report, the effects of diurectic agents are reviewed in sev• eral SD cases with complaints of ear fullness.:
Clinical data and results
Twenty-eight SD cases treated and followed be• tween 1999 and 2003 were reviewed. The diagnos• tic criteria and therapeutic outcome assessment recommendations published in Chinese Journal of Otorhinolaryngology in 1997 were used. Hearing loss was graded using Goodman's classification (1965) . The patients included 14 man and 14 wom• en, aged from 12 to 63 years. Of these patients, 66.3% were young or middle aged(21 to 50 years) adults. Tinnitus was present in 25 cases and verti• go in 12 cases.
In addition to auditory symptoms, hyperlipemia (n=3) , combined hyperlipemia/hypertension (n= 1)and combined hyperglycemia/adiposis hepatica (n=1)were also identified in some patients. In 23 cases, treatment was started with only agents routinely used by the authors for SD, which included nimodipine, betahistine, vitamin B com• plex, ginkgo biloba, danshen root, Jingwu capsule (containing fleeceflower root, solomonseal rhi• zome, glossy privet fruit and yerbadetajo herb) , and mecobalamine. Treatments were started with• in 1 day of onset of symptoms in 3 cases, within 1 week in15 cases, between 8 and 15 days in 3 cases, and between 23 and 30 days in 2 cases. See table 1   ·  ·35 for audiometric classification and final treatment outcomes in these 23 cases..
In 15 of these cases, hearing failed to improve• ment following initial conventional treatment. In 8 of the 15 cases, the patient reported singnificant sensation of fullness in the affected ear, which was considered an indication of endolymphatic hy• drops. Other symptoms in the 8 cases included co• existing tinnitus and vertigo (n=3) and stand-alone tinnitus or vertigo(n=2) . Furosemide test was conducted and positive in 2 cases. Glycer• ol test was performed and showed negative results in 3 cases,,including 1 that showed positive furose• mide test results. Diuretic agents were used in these 8 cases, which included dihydrochlorothia• zide/triamterene(25/50 mg) b.i.d.(n=3) , alismae rhizome q.d. (n=4) , and Wuling (dried xylaria)pow• der q.d.(n=1) . Hearing improvement was noticed in 4 cases on the 5 th (n=2) , 12 th (n=1)and 14 th (n=1) therapeutic days. Of these 4 cases, 1 was tested positive on furosemide test, 1 negative on glycerol test, and the rest 2 were not tested. During the 6-24 month follow up period, their auditory thresh• old fluctuation was within 10 dB,wth no recur• rence of vertigo, although residual dizziness was reported in 1 case. Encouraged by this experience, we decided to in• clude diuretic agents in the initial treatment for the subsequent 5 SD cases, who complained of sen• sation of fullness or vertigo in addition to hearing loss. Complete hearing recovery was achieved in 4 of the 5 cases, and partial recovery in 1 case. These 5 cases are summarized below:
Case 1: A 61 years old male presented with SD in right ear of 7 days, with heavy fullness but no verti• go. Glycerol test was positive. Audiogram showed midrange hearing loss with a hump pattern in the right ear. healthy patients, whereas the herbal agents may be safe for the old and physically weak. We conclude that endolymphatic hydrops may be involved in some SD cases and, when not contraindicated, treatment can be safely combined with diuretic agents.
